Home Healthcare Biotechnology Oncolytic Virus Therapies Market

Oncolytic Virus Therapies Market Size, Share & Trends Analysis Report By Commercialized Therapies (Imlygic, Oncorine, RIGVIR), By Pipeline Therapies (Phase I, Phase II, Phase III, Phase IV), By Type of Virus (Genetically Engineered Oncolytic Virus, Reovirus (Respiratory Enteric Orphan Virus)), By Application (Solid Tumor, Hematological Malignancies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Oncolytic Virus Therapies Market Size Analysis
    1. Introduction
    2. Oncolytic Virus Therapies Market Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
      1. Imlygic
      2. Oncorine
      3. RIGVIR
    3. Oncolytic Virus Therapies Market Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    4. Oncolytic Virus Therapies Market Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
      1. Genetically Engineered Oncolytic Virus
        1. Herpes Simplex Virus (HSV)
        2. Adenovirus
        3. Vaccinia Virus
        4. Oncolytic Wild-Type Virus
      2. Reovirus (Respiratory Enteric Orphan Virus)
        1. Newcastle Disease Virus (NDV)
        2. Vesicolar Stomatitis Virus (VSV)
    5. Oncolytic Virus Therapies Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Solid Tumor
        1. Breast Cancer
        2. Prostate Cancer
        3. Lung Cancer
        4. Glioblastoma
        5. Melanoma
        6. Other Applications
      2. Hematological Malignancies
        1. Lymphoma
        2. Leukemia
        3. Myeloma
  7. North America Oncolytic Virus Therapies Market Size Analysis
    1. Introduction
    2. Oncolytic Virus Therapies Market Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
      1. Imlygic
      2. Oncorine
      3. RIGVIR
    3. Oncolytic Virus Therapies Market Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    4. Oncolytic Virus Therapies Market Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
      1. Genetically Engineered Oncolytic Virus
        1. Herpes Simplex Virus (HSV)
        2. Adenovirus
        3. Vaccinia Virus
        4. Oncolytic Wild-Type Virus
      2. Reovirus (Respiratory Enteric Orphan Virus)
        1. Newcastle Disease Virus (NDV)
        2. Vesicolar Stomatitis Virus (VSV)
    5. Oncolytic Virus Therapies Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Solid Tumor
        1. Breast Cancer
        2. Prostate Cancer
        3. Lung Cancer
        4. Glioblastoma
        5. Melanoma
        6. Other Applications
      2. Hematological Malignancies
        1. Lymphoma
        2. Leukemia
        3. Myeloma
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
  8. Europe Oncolytic Virus Therapies Market Size Analysis
    1. Introduction
    2. Oncolytic Virus Therapies Market Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
      1. Imlygic
      2. Oncorine
      3. RIGVIR
    3. Oncolytic Virus Therapies Market Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    4. Oncolytic Virus Therapies Market Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
      1. Genetically Engineered Oncolytic Virus
        1. Herpes Simplex Virus (HSV)
        2. Adenovirus
        3. Vaccinia Virus
        4. Oncolytic Wild-Type Virus
      2. Reovirus (Respiratory Enteric Orphan Virus)
        1. Newcastle Disease Virus (NDV)
        2. Vesicolar Stomatitis Virus (VSV)
    5. Oncolytic Virus Therapies Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Solid Tumor
        1. Breast Cancer
        2. Prostate Cancer
        3. Lung Cancer
        4. Glioblastoma
        5. Melanoma
        6. Other Applications
      2. Hematological Malignancies
        1. Lymphoma
        2. Leukemia
        3. Myeloma
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    8. France
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
  9. APAC Oncolytic Virus Therapies Market Size Analysis
    1. Introduction
    2. Oncolytic Virus Therapies Market Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
      1. Imlygic
      2. Oncorine
      3. RIGVIR
    3. Oncolytic Virus Therapies Market Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    4. Oncolytic Virus Therapies Market Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
      1. Genetically Engineered Oncolytic Virus
        1. Herpes Simplex Virus (HSV)
        2. Adenovirus
        3. Vaccinia Virus
        4. Oncolytic Wild-Type Virus
      2. Reovirus (Respiratory Enteric Orphan Virus)
        1. Newcastle Disease Virus (NDV)
        2. Vesicolar Stomatitis Virus (VSV)
    5. Oncolytic Virus Therapies Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Solid Tumor
        1. Breast Cancer
        2. Prostate Cancer
        3. Lung Cancer
        4. Glioblastoma
        5. Melanoma
        6. Other Applications
      2. Hematological Malignancies
        1. Lymphoma
        2. Leukemia
        3. Myeloma
    6. China
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    9. India
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
  10. Middle East and Africa Oncolytic Virus Therapies Market Size Analysis
    1. Introduction
    2. Oncolytic Virus Therapies Market Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
      1. Imlygic
      2. Oncorine
      3. RIGVIR
    3. Oncolytic Virus Therapies Market Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    4. Oncolytic Virus Therapies Market Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
      1. Genetically Engineered Oncolytic Virus
        1. Herpes Simplex Virus (HSV)
        2. Adenovirus
        3. Vaccinia Virus
        4. Oncolytic Wild-Type Virus
      2. Reovirus (Respiratory Enteric Orphan Virus)
        1. Newcastle Disease Virus (NDV)
        2. Vesicolar Stomatitis Virus (VSV)
    5. Oncolytic Virus Therapies Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Solid Tumor
        1. Breast Cancer
        2. Prostate Cancer
        3. Lung Cancer
        4. Glioblastoma
        5. Melanoma
        6. Other Applications
      2. Hematological Malignancies
        1. Lymphoma
        2. Leukemia
        3. Myeloma
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
  11. LATAM Oncolytic Virus Therapies Market Size Analysis
    1. Introduction
    2. Oncolytic Virus Therapies Market Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
      1. Imlygic
      2. Oncorine
      3. RIGVIR
    3. Oncolytic Virus Therapies Market Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    4. Oncolytic Virus Therapies Market Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
      1. Genetically Engineered Oncolytic Virus
        1. Herpes Simplex Virus (HSV)
        2. Adenovirus
        3. Vaccinia Virus
        4. Oncolytic Wild-Type Virus
      2. Reovirus (Respiratory Enteric Orphan Virus)
        1. Newcastle Disease Virus (NDV)
        2. Vesicolar Stomatitis Virus (VSV)
    5. Oncolytic Virus Therapies Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Solid Tumor
        1. Breast Cancer
        2. Prostate Cancer
        3. Lung Cancer
        4. Glioblastoma
        5. Melanoma
        6. Other Applications
      2. Hematological Malignancies
        1. Lymphoma
        2. Leukemia
        3. Myeloma
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Commercialized Therapies 2022-2034 (USD MILLION/ Units)
        1. Imlygic
        2. Oncorine
        3. RIGVIR
      3. Market Size & Forecast By Pipeline Therapies 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      4. Market Size & Forecast By Type of Virus 2022-2034 (USD MILLION/ Units)
        1. Genetically Engineered Oncolytic Virus
          1. Herpes Simplex Virus (HSV)
          2. Adenovirus
          3. Vaccinia Virus
          4. Oncolytic Wild-Type Virus
        2. Reovirus (Respiratory Enteric Orphan Virus)
          1. Newcastle Disease Virus (NDV)
          2. Vesicolar Stomatitis Virus (VSV)
      5. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Solid Tumor
          1. Breast Cancer
          2. Prostate Cancer
          3. Lung Cancer
          4. Glioblastoma
          5. Melanoma
          6. Other Applications
        2. Hematological Malignancies
          1. Lymphoma
          2. Leukemia
          3. Myeloma
  12. Competitive Landscape
    1. Oncolytic Virus Therapies Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Amgen Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. DAIICHI SANKYO COMPANY LIMITED
    3. DNAtrix
    4. Genelux
    5. Oncolytics Biotech Inc
    6. PsiOxus Therapeutics
    7. RIGVIR Ltd
    8. Shanghai Sunway Biotech Co. Ltd.
    9. SillaJen Inc
    10. Sorrento Therapeutics Inc
    11. Takara Bio Inc
    12. Transgene SA
    13. VCNBiosciences
    14. ViroCure
    15. Viralytics Ltd.(Merck & Co., Inc.) 
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Oncolytic Virus Therapies Market Size and Forecast By Regions - 2022-2034 (USD Million)

Table 2: Global Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 3: Global Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 4: Global Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 5: Global Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 6: North America Oncolytic Virus Therapies Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 7: North America Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 8: North America Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 9: North America Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 10: North America Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 11: U.S. Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 12: U.S. Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 13: U.S. Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 14: U.S. Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 15: Canada Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 16: Canada Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 17: Canada Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 18: Canada Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 19: Europe Oncolytic Virus Therapies Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 20: Europe Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 21: Europe Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 22: Europe Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 23: Europe Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 24: U.K. Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 25: U.K. Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 26: U.K. Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 27: U.K. Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 28: Germany Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 29: Germany Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 30: Germany Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 31: Germany Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 32: France Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 33: France Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 34: France Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 35: France Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 36: Spain Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 37: Spain Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 38: Spain Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 39: Spain Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 40: Italy Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 41: Italy Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 42: Italy Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 43: Italy Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 44: Russia Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 45: Russia Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 46: Russia Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 47: Russia Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 48: Nordic Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 49: Nordic Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 50: Nordic Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 51: Nordic Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 52: Benelux Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 53: Benelux Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 54: Benelux Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 55: Benelux Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 56: Rest of Europe Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 57: Rest of Europe Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 58: Rest of Europe Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 59: Rest of Europe Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 60: APAC Oncolytic Virus Therapies Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 61: APAC Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 62: APAC Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 63: APAC Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 64: APAC Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 65: China Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 66: China Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 67: China Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 68: China Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 69: Korea Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 70: Korea Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 71: Korea Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 72: Korea Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 73: Japan Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 74: Japan Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 75: Japan Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 76: Japan Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 77: India Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 78: India Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 79: India Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 80: India Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 81: Australia Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 82: Australia Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 83: Australia Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 84: Australia Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 85: Taiwan Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 86: Taiwan Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 87: Taiwan Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 88: Taiwan Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 89: South East Asia Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 90: South East Asia Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 91: South East Asia Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 92: South East Asia Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 93: Rest of Asia-Pacific Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 94: Rest of Asia-Pacific Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 95: Rest of Asia-Pacific Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 96: Rest of Asia-Pacific Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 97: Middle East and Africa Oncolytic Virus Therapies Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 98: Middle East and Africa Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 99: Middle East and Africa Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 100: Middle East and Africa Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 101: Middle East and Africa Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 102: UAE Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 103: UAE Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 104: UAE Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 105: UAE Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 106: Turkey Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 107: Turkey Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 108: Turkey Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 109: Turkey Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 110: Saudi Arabia Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 111: Saudi Arabia Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 112: Saudi Arabia Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 113: Saudi Arabia Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 114: South Africa Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 115: South Africa Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 116: South Africa Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 117: South Africa Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 118: Egypt Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 119: Egypt Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 120: Egypt Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 121: Egypt Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 122: Nigeria Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 123: Nigeria Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 124: Nigeria Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 125: Nigeria Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 126: Rest of MEA Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 127: Rest of MEA Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 128: Rest of MEA Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 129: Rest of MEA Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 130: LATAM Oncolytic Virus Therapies Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 131: LATAM Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 132: LATAM Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 133: LATAM Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 134: LATAM Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 135: Brazil Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 136: Brazil Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 137: Brazil Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 138: Brazil Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 139: Mexico Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 140: Mexico Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 141: Mexico Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 142: Mexico Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 143: Argentina Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 144: Argentina Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 145: Argentina Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 146: Argentina Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 147: Chile Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 148: Chile Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 149: Chile Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 150: Chile Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 151: Colombia Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 152: Colombia Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 153: Colombia Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 154: Colombia Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Table 155: Rest of LATAM Oncolytic Virus Therapies Market Size and Forecast By Commercialized Therapies - 2022-2034 (USD Million)

Table 156: Rest of LATAM Oncolytic Virus Therapies Market Size and Forecast By Pipeline Therapies - 2022-2034 (USD Million)

Table 157: Rest of LATAM Oncolytic Virus Therapies Market Size and Forecast By Type of Virus - 2022-2034 (USD Million)

Table 158: Rest of LATAM Oncolytic Virus Therapies Market Size and Forecast By Application - 2022-2034 (USD Million)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.